These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9258902)

  • 1. Nigrostriatal monoamine oxidase A and B in aging squirrel monkeys and C57BL/6 mice.
    Irwin I; Delanney L; Chan P; Sandy MS; Di Monte DA; Langston JW
    Neurobiol Aging; 1997; 18(2):235-41. PubMed ID: 9258902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
    Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
    Finnegan KT; Irwin I; Delanney LE; Langston JW
    J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment.
    Irwin I; Finnegan KT; Delanney LE; Di Monte D; Langston JW
    Brain Res; 1992 Feb; 572(1-2):224-31. PubMed ID: 1611516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studies.
    Del Zompo M; Piccardi MP; Bernardi F; Bonuccelli U; Corsini GU
    Brain Res; 1986 Jul; 378(2):320-4. PubMed ID: 3089539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Melamed E; Rosenthal J; Youdim MB
    J Neurochem; 1990 Oct; 55(4):1427-31. PubMed ID: 2398363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity in MPTP-treated squirrel monkeys: in vivo and in vitro investigations.
    Yee RE; Huang SC; Stout DB; Irwin I; Shoghi-Jadid K; Togaski DM; DeLanney LE; Langston JW; Satyamurthy N; Farahani KF; Phelps ME; Barrio JR
    J Neurochem; 2000 Mar; 74(3):1147-57. PubMed ID: 10693947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intra- and extrasynaptosomal monoamine oxidase-A and -B activities in the striatum and frontal cortex of two mice strains with different sensitivities to the neurotoxic actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Stenström A; Sundström E; Fowler CJ
    Pharmacol Toxicol; 1989 Mar; 64(3):276-81. PubMed ID: 2786196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
    Ito T; Suzuki K; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Youngster SK; Sonsalla PK; Heikkila RE
    J Neurochem; 1987 Mar; 48(3):929-34. PubMed ID: 3492590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Monoamine Oxidase in the Nigrostriatal System at Presymptomatic and Early Symptomatic Stages of Parkinsonism in Mice.
    Khakimova GR; Kozina EA; Buneeva OA; Aksenova LN; Medvedev AE; Ugryumov MV
    Bull Exp Biol Med; 2015 Aug; 159(4):456-8. PubMed ID: 26388575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidases of the brains and livers of macaque and cercopithecus monkeys.
    Riachi NJ; Harik SI
    Exp Neurol; 1992 Feb; 115(2):212-7. PubMed ID: 1735467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of rat striatal monoamine oxidase activities towards dopamine, serotonin and kynuramine by gradient centrifugation and nigro-striatal lesions.
    Van der Krogt JA; Koot-Gronsveld E; Van den Berg CJ
    Life Sci; 1983 Aug; 33(7):615-23. PubMed ID: 6877035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Andersen JK; Frim DM; Isacson O; Beal MF; Breakefield XO
    Brain Res; 1994 Sep; 656(1):108-14. PubMed ID: 7804823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
    Harik SI; Riachi NJ; Hritz MA; Berridge MS; Sayre LM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):790-5. PubMed ID: 8355208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
    Sagi Y; Weinstock M; Youdim MB
    J Neurochem; 2003 Jul; 86(2):290-7. PubMed ID: 12871570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
    Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment of aged mice with L-deprenyl produces marked striatal MAO-B inhibition but no beneficial effects on survival, motor performance, or nigral lipofuscin accumulation.
    Ingram DK; Wiener HL; Chachich ME; Long JM; Hengemihle J; Gupta M
    Neurobiol Aging; 1993; 14(5):431-40. PubMed ID: 8247225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
    Demarest KT; Smith DJ; Azzaro AJ
    J Pharmacol Exp Ther; 1980 Nov; 215(2):461-8. PubMed ID: 7441510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.